Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C

Transplant International

Volumn 24, Issue 1, 2011, Pages 43-50

  Bitetto, Davide ^a   Fabris, Carlo ^a   Fornasiere, Ezio ^a   Pipan, Corrado ^a   Fumolo, Elisa ^a   Cussigh, Annarosa ^a   Bignulin, Sara ^a   Cmet, Sara ^a   Fontanini, Elisabetta ^a   Falleti, Edmondo ^a   Martinella, Romina ^a   Pirisi, Mario ^b   Toniutto, Pierluigi ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

interferon; liver transplantation; recurrent hepatitis C; vitamin D

Indexed keywords

ALPHA INTERFERON; COLECALCIFEROL; CYCLOSPORIN; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; TACROLIMUS; VITAMIN D;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHOLECALCIFEROL; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78650008697     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01141.x     Document Type: Article

References (36)

1. Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 1231.
2. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823.
3. Everhart JE, Wei Y, Eng H, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 1999; 29: 1220.
4. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673.
5. Berenguer M,. What determines the natural history of recurrent hepatitis C after liver transplantation? J Hepatol 2005; 42: 448.
6. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR,. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889.
7. Watt K, Veldt B, Charlton M,. A practical guide to the management of HCV infection following liver transplantation. Am J Transplant 2009; 9: 1707.
8. Everson GT, Trotter J, Forman L, et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 2005; 42: 255.
9. Chalasani N, Manzarbeitia C, Ferenci P, et al. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology 2005; 41: 289.
10. Samuel D, Bizollon T, Feray C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003; 124: 642.
11. Berenguer M,. Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. J Hepatol 2008; 49: 274.
12. Dumortier J, Scoazec JY, Chevallier P, Boillot O,. Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination. J Hepatol 2004; 40: 669.
13. Carrion JA, Navasa M, Garcia-Retortillo M, et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 2007; 132: 1746.
14. Gurusamy KS, Osmani B, Xirouchakis E, Burroughs AK, Davidson BR,. Antiviral therapy for recurrent liver graft infection with hepatitis C virus. Cochrane Database Syst Rev 2009; CD006803.
15. Feray C, Samuel D, Gigou M, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995; 22: 1084.
16. Berenguer M, Palau A, Fernandez A, et al. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2006; 12: 1067.
17. Inoue K, Sekiyama K, Yamada M, Watanabe T, Yasuda H, Yoshiba M,. Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. J Gastroenterol 2003; 38: 567.
18. Firpi RJ, Zhu H, Morelli G, et al. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl 2006; 12: 51.
19. Holick MF,. Vitamin D deficiency. N Engl J Med 2007; 357: 266.
20. Bitetto D, Fabris C, Falleti E, et al. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int 2010; 30: 417.
21. Petta S, Camma C, Scazzone C, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51: 1158.
22. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696.
23. Lin R, White JH,. The pleiotropic actions of vitamin D. Bioessays 2004; 26: 21.
24. Liu PT, Modlin RL,. Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol 2008; 20: 371.
25. White JH,. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun 2008; 76: 3837.
26. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000; 355: 618.
27. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN,. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 2005; 50: 432.
28. Nnoaham KE, Clarke A,. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113.
29. Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008; 46: 443.
30. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770.
31. Wang TT, Dabbas B, Laperriere D, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 2010; 285: 2227.
32. Muhe L, Lulseged S, Mason KE, Simoes EA,. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997; 349: 1801.
33. Aloia JF, Li-Ng M,. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007; 135: 1095. author reply 1097.
34. Holick MF,. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062.
35. Oton E, Barcena R, Moreno-Planas JM, et al. Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin. Am J Transplant 2006; 6: 2348.
36. Manousou P, Samonakis D, Cholongitas E, et al. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. Liver Transpl 2009; 15: 1783.